This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02097/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02097/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02097/identifier/pubchem-substance/
n14http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB02097/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02097/identifier/chemspider/
n6http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02097/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02097
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB02097 n14:DB02097
dcterms:title
Cytidine
adms:identifier
n8:453552 n9:46507502 n10:DB02097 n11:CTN n12:17562 n13:576
n5:synthesisReference
Kiyoshi Nakayama, Hiroshi Hagino, "Method for preparing cytidine diphosphate choline." U.S. Patent USRE0288861, issued August 15, 1972.
n5:IUPAC-Name
n6:271B6460-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6466-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6465-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6462-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B6463-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6464-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B645E-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B645C-363D-11E5-9242-09173F13E4C5 n6:271B645F-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B645D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B646C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B646D-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6467-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6468-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B646A-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6469-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B646B-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6472-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6474-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6475-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6471-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6470-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B6473-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6461-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B646E-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B646F-363D-11E5-9242-09173F13E4C5